Submitted by Anonymous (not verified) on 1 June 2026 - 15:44
Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 4, Status: Authorised
Source: